Investors Sell Monsanto Company (MON) on Strength Following Insider Selling
Investors sold shares of Monsanto Company (NYSE:MON) on strength during trading hours on Friday following insider selling activity. $23.85 million flowed into the stock on the tick-up and $89.73 million flowed out of the stock on the tick-down, for a money net flow of $65.88 million out of the stock. Of all stocks tracked, Monsanto Company had the 0th highest net out-flow for the day. Monsanto Company traded up $0.29 for the day and closed at $107.62Specifically, EVP Kerry J. Preete sold 2,745 shares of the stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the sale, the executive vice president now owns 50,056 shares in the company, valued at $5,053,653.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Steven Mizell sold 2,525 shares of the stock in a transaction on Tuesday, January 10th. The stock was sold at an average price of $108.56, for a total value of $274,114.00. Following the sale, the executive vice president now owns 43,711 shares in the company, valued at approximately $4,745,266.16. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.
MON has been the topic of several research analyst reports. Sanford C. Bernstein upgraded Monsanto Company from an “underperform” rating to a “market perform” rating and increased their target price for the stock from $82.81 to $105.00 in a report on Monday, September 26th. J P Morgan Chase & Co set a $128.00 price target on Monsanto Company and gave the company a “buy” rating in a report on Thursday, October 6th. Deutsche Bank AG reiterated a “buy” rating on shares of Monsanto Company in a report on Thursday, October 6th. Zacks Investment Research cut Monsanto Company from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Finally, CLSA upgraded Monsanto Company from an “underperform” rating to an “outperform” rating in a report on Friday, January 6th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seventeen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $114.46.
The company has a 50-day moving average of $105.26 and a 200 day moving average of $103.92. The firm has a market capitalization of $47.20 billion, a P/E ratio of 29.51 and a beta of 1.01.
Monsanto Company (NYSE:MON) last posted its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.20. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The business had revenue of $2.22 billion for the quarter. During the same period last year, the company posted ($0.11) earnings per share. The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. Analysts anticipate that Monsanto Company will post $4.73 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Friday, January 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend is Wednesday, January 4th. Monsanto Company’s dividend payout ratio (DPR) is currently 58.86%.
Hedge funds and other institutional investors have recently bought and sold shares of the company. HL Financial Services LLC increased its position in Monsanto Company by 49.1% in the second quarter. HL Financial Services LLC now owns 8,525 shares of the company’s stock worth $882,000 after buying an additional 2,807 shares during the period. Rehmann Capital Advisory Group increased its position in Monsanto Company by 13.4% in the second quarter. Rehmann Capital Advisory Group now owns 8,087 shares of the company’s stock worth $836,000 after buying an additional 953 shares during the period. Callahan Advisors LLC increased its position in Monsanto Company by 2.6% in the second quarter. Callahan Advisors LLC now owns 8,547 shares of the company’s stock worth $884,000 after buying an additional 217 shares during the period. Destination Wealth Management increased its position in Monsanto Company by 42.1% in the second quarter. Destination Wealth Management now owns 72,219 shares of the company’s stock worth $7,468,000 after buying an additional 21,380 shares during the period. Finally, Albion Financial Group UT purchased a new position in Monsanto Company during the second quarter worth $210,000. 73.70% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.